SAN DIEGO , April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022 , after the market close on Wednesday, May 11, 2022 . Ron Rocca , Exagen’s President and Chief Executive